Mesothelioma Legal News

Galion Neighbors Now Hearing About Asbestos Discovered In 2010

Neighbors in Galion are just now finding out about asbestos that was discovered at on old manufacturing plant in 2010.

SELLAS Life Sciences Group Announces Upcoming Presentation Of Phase 2 …

In addition, SELLAS announced today that ZELTHERVA has been formally accepted by the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research as the proprietary name for SELLAS ‘s WT1 vaccine is a late clinical-stage cancer immu…

$55 Million To Be Paid By Johnson & Johnson In Talcum Powder Case

Johnson & Johnson was ordered to pay $55 million in a talcum powder case for feminine hygiene products that caused ovarian cancer.

Canada’s Prime Minister Trudeau Commits to Ban Asbestos

Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation’s asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban,” Trudeau said. “We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau…

The post Canada’s Prime Minister Trudeau Commits to Ban Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Canada’s Prime Minister Trudeau Commits to Ban Asbestos

Canadian Prime Minister Justin Trudeau recently announced what labor and public health groups have spent years waiting to hear about the nation’s asbestos epidemic. “We’ve actually made the commitment that we are moving forward on a ban,” Trudeau said. “We know that its impact on workers far outweighs any benefits that it might provide.” Trudeau…

The post Canada’s Prime Minister Trudeau Commits to Ban Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Bayer to Showcase Latest Oncology Research at ASCO 2016

Bayer announced today that data from several studies across its oncology portfolio will be presented at the 52 Annual Meeting of the American Society of Clinical Oncology , taking place June 3-7 in Chicago. The data represent clinical research on Bayer’s oncology products, as well as continued investigation of Xofigo injection in other areas of metastatic castration-resistant prostate cancer .

Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting

The avelumab presentations, from the rapidly accelerating JAVELIN clinical development program, include new study results from a number of difficult-to-treat cancers, including data from the pivotal Phase II trial of avelumab being investigated as seco…